Trials / Completed
CompletedNCT00154063
Efficacy and Safety Study of E2007 in Migraine Prophylaxis
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This was a 22-week, prospective, randomized, double-blind, placebo-controlled, multicenter, parallel-group study that included a 4-week Baseline Phase at the beginning and a 4-week single-blind placebo Safety Phase at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E2007 | |
| OTHER | Placebo |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2005-09-12
- Last updated
- 2015-06-08
- Results posted
- 2015-06-08
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00154063. Inclusion in this directory is not an endorsement.